MyShare
US Market news
headline news | recent news | latest news | market news | recent topics | stock topics
Global news - chevrons indicate local prediction, arrows show global predictions, circles show importance
| NFLX US | Netflix blows past earnings estimates as subscribers jump 16% Netflix reported earnings after the bell. Here are the results. - cnbc | 18m ago link | |
| IRTC US | iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024 SAN FRANCISCO, April 18, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC ), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2024 after the close of trading on Thursday, May 2, 2024. The ... Full story available on Benzinga.com - benzinga | 24m ago link | |
| MDB US | MongoDB, Inc. to Host Investor Session at MongoDB.local NYC 2024 NEW YORK, April 18, 2024 /PRNewswire/ -- MongoDB, Inc. (NASDAQ: MDB) today announced that it will host an investor session at MongoDB.local in New York City. The day will begin at 10:00 a.m. ET on Thursday, May 2nd with MongoDB.local keynote presentations from Dev Ittycheria, MongoDB's... - prnewswire:443 | 24m ago link | |
| NTNX US | What the Options Market Tells Us About Nutanix Whales with a lot of money to spend have taken a noticeably bearish stance on Nutanix . Looking at options history for Nutanix (NASDAQ: NTNX ) we detected 9 trades. If we consider the specifics of each trade, it is accurate to state that 11% of the investors opened trades with bullish expectations and 88% with bearish. From the overall spotted trades, 2 are puts, for a total amount of $103,904 and 7, calls, for a total amount of $427,750. Predicted Price Range Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $37.5 to $72.5 for Nutanix over the last 3 months. Insights into Volume & Open Interest Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Nutanix's options at ... Full story available on Benzinga.com - benzinga | 56m ago link | |
| OKTA US | Spotlight on Okta: Analyzing the Surge in Options Activity Deep-pocketed investors have adopted a bullish approach towards Okta (NASDAQ: OKTA ), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in OKTA usually suggests something big is about to happen. We gleaned this information from our observations today when Benzinga's options scanner highlighted 14 extraordinary options activities for Okta. This level of activity is out of the ordinary. The general mood among these heavyweight investors is divided, with 57% leaning bullish and 42% bearish. Among these notable options, 7 are puts, totaling $780,650, and 7 are calls, amounting to $1,614,798. Predicted Price Range After evaluating the trading volumes and Open Interest, it's evident ... Full story available on Benzinga.com - benzinga | 56m ago link | |
| CF US | Spotlight on CF Industries Holdings: Analyzing the Surge in Options Activity Deep-pocketed investors have adopted a bullish approach towards CF Industries Holdings (NYSE: CF ), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CF usually suggests something big is about to happen. We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for CF Industries Holdings. This level of activity is out of the ordinary. The general mood among these heavyweight investors is divided, with 62% leaning bullish and 37% bearish. Among these notable options, 3 are puts, totaling $328,455, and 5 are calls, amounting to $183,379. Projected Price Targets Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $72.5 to $100.0 for CF Industries Ho - benzinga | 56m ago link | |
| HUM US | Here's How Much You Would Have Made Owning Humana Stock In The Last 20 Years Humana (NYSE: HUM ) has outperformed the market over the past 20 years by 8.13% on an annualized basis producing an average annual return of 15.79%. Currently, Humana has a market capitalization of $39.46 billion. Buying $1000 In HUM: If an ... Full story available on Benzinga.com - benzinga | 59m ago link | |
| ASND US | $1000 Invested In Ascendis Pharma 15 Years Ago Would Be Worth This Much Today Ascendis Pharma (NASDAQ: ASND ) has outperformed the market over the past 15 years by 17.87% on an annualized basis producing an average annual return of 30.26%. Currently, Ascendis Pharma has a market capitalization of $8.05 billion. Buying $1000 In ASND: If ... Full story available on Benzinga.com - benzinga | 59m ago link | |
| EXPE US | In-Depth Examination Of 10 Analyst Recommendations For Expedia Group In the latest quarter, 10 analysts provided ratings for Expedia Group (NASDAQ: EXPE ), showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 1 8 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 1 0 0 2M Ago 0 0 0 0 0 3M Ago 1 1 6 0 0 In the assessment of 12-month price targets, analysts unveil insights for Expedia Group, presenting an average target of $150.2, a high estimate of $180.00, and a low estimate of $130.00. This current average has increased by 5.18% from the previous average price target of $142.80. Exploring Analyst Ratings: An In-Depth Overview A comprehensive examination of how financial experts perceive Expedia Group i - benzinga | 1h ago link | |
| BLDR US | Navigating 10 Analyst Ratings For Builders FirstSource Across the recent three months, 10 analysts have shared their insights on Builders FirstSource (NYSE: BLDR ), expressing a variety of opinions spanning from bullish to bearish. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 5 2 0 0 Last 30D 1 0 0 0 0 1M Ago 0 1 1 0 0 2M Ago 1 3 1 0 0 3M Ago 1 1 0 0 0 In the assessment of 12-month price targets, analysts unveil insights for Builders FirstSource, presenting an average target of $219.6, a high estimate of $242.00, and a low estimate of $185.00. This upward trend is evident, with the current average reflecting a 9.47% increase from the previous average price target of $200.60. Investigating Analyst Ratings - benzinga | 1h ago link | |
| MSFT US | Microsoft's Strategic Emphasis on AI and Cloud Services Signals Strong Future Performance: Analysts Citigroup analyst Tyler Radke maintained Microsoft Corp (NASDAQ: MSFT ) with a Buy and lowered the price target from $480 to $475 . The analyst remained positive on Microsoft ahead of third-quarter results as his quarterly inputs point to strengthening Azure growth trends boosted again by AI services, with solid CoPilot interest, though more bite-sized deals initially. Radke’s strong inputs and a more positive PC backdrop against conservative guidance should yield room for upside across key KPIs (including Azure, which should reaccelerate), while he expects continued cost discipline to drive strong EPS upside. BofA Securities analyst Brad Sills reiterated a Buy rating on Microsoft with a price target of $480. Following a round of calls with nearly a dozen key Microso partners, the analyst expects a healthy 1% upside to his third-quarter revenue estimate of $60.5 billion, stemming from sustained strength in Azure and M365. - benzinga | 1h ago link | |
| EXPE US | Expedia Group Unusual Options Activity For April 18 Deep-pocketed investors have adopted a bearish approach towards Expedia Group (NASDAQ: EXPE ), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in EXPE usually suggests something big is about to happen. We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Expedia Group. This level of activity is out of the ordinary. The general mood among these heavyweight investors is divided, with 33% leaning bullish and 66% bearish. Among these notable options, 6 are puts, totaling $228,264, and 3 are calls, amounting to $209,200. Predicted Price Range Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $115.0 to $130.0 for Expedia Group during the past - benzinga | 1h ago link | |
| BIIB US | Biogen Unusual Options Activity For April 18 Deep-pocketed investors have adopted a bearish approach towards Biogen (NASDAQ: BIIB ), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in BIIB usually suggests something big is about to happen. We gleaned this information from our observations today when Benzinga's options scanner highlighted 36 extraordinary options activities for Biogen. This level of activity is out of the ordinary. The general mood among these heavyweight investors is divided, with 13% leaning bullish and 86% bearish. Among these notable options, 4 are puts, totaling $206,242, and 32 are calls, amounting to $10,097,960. What's The Price Target? After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $110.0 and $230.0 for Biogen, spannin - benzinga | 1h ago link | |
| GBTC US | Ripples Top Lawyer Sets The Record Straight On Next Steps In SEC Case Is $1 XRP In Sight? Stuart Alderoty, the chief legal officer at fintech firm Ripple, has cleared the air on the forthcoming court proceedings. - zycrypto | 1h ago link | |
| KLAC US | KLA Unusual Options Activity For April 18 Whales with a lot of money to spend have taken a noticeably bearish stance on KLA . Looking at options history for KLA (NASDAQ: KLAC ) we detected 9 trades. If we consider the specifics of each trade, it is accurate to state that 11% of the investors opened trades with bullish expectations and 88% with bearish. From the overall spotted trades, 7 are puts, for a total amount of $333,516 and 2, calls, for a total amount of $71,015. What's The Price Target? Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $600.0 to $720.0 for KLA over the last 3 months. Volume & Open Interest Trends In today's trading context, the average open interest for options of KLA stands at 71.67, with a total volume reaching 16.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in KLA, ... Full story available on Benzinga.co - benzinga | 1h ago link | |
| EL US | Estee Lauder Cos Unusual Options Activity Deep-pocketed investors have adopted a bearish approach towards Estee Lauder Cos (NYSE: EL ), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in EL usually suggests something big is about to happen. We gleaned this information from our observations today when Benzinga's options scanner highlighted 17 extraordinary options activities for Estee Lauder Cos. This level of activity is out of the ordinary. The general mood among these heavyweight investors is divided, with 47% leaning bullish and 52% bearish. Among these notable options, 3 are puts, totaling $334,740, and 14 are calls, amounting to $972,100. Expected Price Movements Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $110.0 to $150.0 for Estee Lauder ... Full - benzinga | 1h ago link | |
| ALB US | Here's How Much You Would Have Made Owning Albemarle Stock In The Last 20 Years Albemarle (NYSE: ALB ) has outperformed the market over the past 20 years by 2.77% on an annualized basis producing an average annual return of 10.42%. Currently, Albemarle has a market capitalization of $13.06 billion. Buying $1000 In ALB: If an ... Full story available on Benzinga.com - benzinga | 1h ago link | |
| CC US | ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages The Chemours Company Investors to Secure Counsel Before Important Deadline in Securities Class Action - CC NEW YORK, April 18, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of The Chemours Company (NYSE: CC) between February 10, 2023 and February 28, 2024, both dates inclusive (the 'Class Period'), of the important May 20, 2024... - prnewswire:443 | 2h ago link | |
| TSLA US | Should I tax loss harvest Tesla? Given all the bad news and potentially more to come, it feels like it could be a good opportunity to sell Tesla and then rebuy it in 31 days after more bad news, ratings downgrades, lower price targets, etc... all come into the picture. Do you think this is a risky move? What could drive the stock higher between now and then? I know earnings is coming up, but I'd be surprised if good news came out of that. submitted by /u/curious_mj [link] [comments] - reddit | 2h ago link | |
| LOW US | $1000 Invested In Lowe's Companies 20 Years Ago Would Be Worth This Much Today Lowe's Companies (NYSE: LOW ) has outperformed the market over the past 20 years by 3.68% on an annualized basis producing an average annual return of 11.34%. Currently, Lowe's Companies has a market capitalization of $130.60 billion. Buying $1000 In LOW: If ... Full story available on Benzinga.com - benzinga | 2h ago link | |
| MMC US | Marsh & McLennan Companies (MMC) Q1 2024 Earnings Call Transcript MMC earnings call for the period ending March 31, 2024. - fool | 2h ago link | |
| BMI US | Ally Financial Reports Upbeat Earnings, Joins Badger Meter, Genuine Parts And Other Big Stocks Moving Higher On Thursday U.S. stocks were lower, with the Nasdaq Composite falling over 50 points on Thursday. Shares of Ally Financial Inc. (NYSE: ALLY ) rose sharply during Thursday's session after the company reported better-than-expected quarterly financial results. Ally Financial posted adjusted earnings of 45 cents per share, beating market estimates of 33 cents per share. The company's adjusted sales came in at $1.99 billion versus expectations of $1.96 billion. Ally Financial shares jumped 7.7% to $39.06 on Thursday. Here are some other big stocks recording losses in today's session. Critical Metals Corp. (NASDAQ: CRML ) rose 24% to $9.30. Canopy Growth Corporation (NASDAQ: CGC ) shares gained 21.2% to $7.86. Humacyte, Inc. (NASDAQ: HUMA ) shares rose 13.9% to $3.5550. Trump Media & Technology Group Corp. (NASDAQ: DJT ) jumped ... Full story available on Benzinga.com - benzinga | 2h ago link | |
| BPTH US | Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules HOUSTON, April 18, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH ) (the 'Company' or 'Bio-Path'), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it has entered into a definitive agreement with certain institutional investors for the issuance and sale of 375,000 shares of its common stock at a purchase price per share of $3.225 in a registered direct offering priced at-the-market under Nasdaq rules. Additionally, in a concurrent private placement, Bio-Path has also agreed to issue to such investors unregistered warrants to purchase up to 375,000 shares of common stock at an exercise price of $3.10 per share. The unregistered warrants to be issued in the private placement will become immediately exercisable upon issuance and will expire five years from the date of issuance. The offering is expected to close on or about April 19 - benzinga | 2h ago link | |
| BPTH US | Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules HOUSTON, April 18, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (Nasdaq: BPTH) (the Company or Bio-Path), a biotechnology company leveraging its proprietary DNAbilize antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it has entered into a definitive agreement with certain institutional investors for the issuance and sale of 375,000 shares of its common stock at a purchase price per share of $3.225 in a registered direct offering priced at-the-market under Nasdaq rules. Additionally, in a concurrent private placement, Bio-Path has also agreed to issue to such investors unregistered warrants to purchase up to 375,000 shares of common stock at an exercise price of $3.10 per share. The unregistered warrants to be issued in the private placement will become immediately exercisable upon issuance and will expire five years from the date of issuance. The offering is expected to close on or about April 19, 2024, sub - globenewswire | 2h ago link | |
| IMAX US | IMAX Gaining On All Grounds - Analyst Highlights StreamSmart Technology And Global Expansion as Catalysts Wedbush analyst Alicia Reese reiterated an Outperform rating on the shares of IMAX Corp (NYSE: IMAX ) with a price target of $22. The company is slated to report its first-quarter FY24 earnings on April 25, Thursday. The analyst expects first-quarter revenue of $82 million vs. the prior estimate of $76 million and consensus of $77 million, with EPS of $0.15 vs. the previous estimate of $0.09 and consensus of $0.08. IMAX reported a total global first-quarter box office on IMAX screens of $260 million, ahead of the $216 million estimate, thereby raising the analyst’s first-quarter revenue estimate by $9 million in revenue from studios and theater partners. The ... Full story available on Benzinga.com - benzinga | 2h ago link | |
| UPS US | A Closer Look at United Parcel Service's Options Market Dynamics Whales with a lot of money to spend have taken a noticeably bearish stance on United Parcel Service . Looking at options history for United Parcel Service (NYSE: UPS ) we detected 9 trades. If we consider the specifics of each trade, it is accurate to state that 22% of the investors opened trades with bullish expectations and 77% with bearish. From the overall spotted trades, 7 are puts, for a total amount of $364,347 and 2, calls, for a total amount of $68,800. Projected Price Targets Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $138.0 to $165.0 for United Parcel Service over the recent three months. Volume & Open Interest Trends In terms of liquidity and interest, the mean open interest for United Parcel Service options trades today is 1459.8 with a total volume of 367.00. In the following chart, we are able to follow the development of volume and open interest of call and put options - benzinga | 2h ago link | |
| AA US | Alcoa Well-Positioned To Benefit From Positive Pricing Momentum, Analyst Says Alcoa Corporation (NYSE: AA ) gets a price target bump from a couple of analysts following better-than-expected first-quarter FY24 results . Yesterday, the company reported an EPS loss of $(0.81), which beat the consensus loss of $(0.55) and revenue of $2.60 billion, beating the consensus estimate of $2.56 billion . Alcoa expects alumina production to be 9.8 million and 10 million metric tons and alumina shipments to be 12.7 million and 12.9 million metric tons for FY24 . BMO Capital Markets analyst Katja Jancic raised the price target to $37 (from $35) and maintained the Market Perform rating. The analyst says Alcoa is well-positioned to benefit from the positive aluminum price momentum and continued multiple actions to deliver profitability improvements over time. Also, Jancic continues to project ... Full story available on Benzinga.com - benzinga | 2h ago link | |
| OCUL US | Ocular Therapeutix Highlights Early Data From Diabetes-Related Eye Disorder On Thursday, Ocular Therapeutix Inc (NASDAQ: OCUL ) announced topline results from the Phase 1 HELIOS study evaluating Axpaxli versus sham control in patients with moderately severe to severe non-proliferative diabetic retinopathy without diabetic macular edema (DME) . 6 of 13 (46.2%) patients in the Axpaxli group experienced a 1 or 2-step improvement in the Diabetic Retinopathy Severity Scale (DRSS) at 40 weeks, with 2 of the 6 having a 2-step improvement. No patients in the control group showed ... Full story available on Benzinga.com - benzinga | 2h ago link | |
| AAPL US | S9, blood-oxygen watchOS update question. Hi all - after reading about the blood oxygen fiasco and Apple Watches with part numbers ending in LW/A, I went and got myself an open-box LL/A last week. Am I safe to go ahead and update the watch to watchOS 10.4 and not lose my lovely oximeter? Any worries about having just registered the watch last week, months after the sales deadline? submitted by /u/Able_Youth_6400 [link] [comments] - reddit | 2h ago link | |
| NKE US | $100 Invested In Nike 20 Years Ago Would Be Worth This Much Today Nike (NYSE: NKE ) has outperformed the market over the past 20 years by 4.65% on an annualized basis producing an average annual return of 12.31%. Currently, Nike has a market capitalization of $143.10 billion. Buying $100 In NKE: If an ... Full story available on Benzinga.com - benzinga | 2h ago link | |
| NFLX US | Netflix is set to report earnings here's what Wall Street expects Netflix's main focus recently has been on juicing profits, not necessarily growing its subscriber count. - cnbc | 3h ago link | |
| WINT US | Why Windtree Therapeutics (WINT) Stock Is Getting Hammered Windtree Therapeutics Inc (NASDAQ: WINT ) shares are trading lower by 20% to $0.32 during Thursday’s session after the company announced it approved a 1-for-18 reverse stock split of its common stock . This measure, effective April 19, 2024, aims to increase the market price per share, ensuring compliance with Nasdaq’s minimum bid price requirement. Each 18 shares will be converted into 1 share without altering the stock’s par value. The split affects all shareholders proportionally and does not change their ownership percentage, with fractional shares rounded up. See Also: Netflix Stock Is ... Full story available on Benzinga.com - benzinga | 3h ago link | |
| SBUX US | Booming cold drink sales mean more plastic waste. So Starbucks redesigned its cups Booming sales of cold drinks at Starbucks stores have created a problem: growing amounts of plastic waste from the single-use cups that Frappuccinos, Refreshers, cold brews and other iced drinks are served in - abcnews | 3h ago link | |
| TSLA US | CNBC Inside India: Musk and Modi Tesla chief Elon Musk is set to meet Indian Prime Minister Narendra Modi soon, and the timing couldn't be any better. - cnbc | 3h ago link | |
| PFPT US | Avanan vs. Proofpoint Hi there We are looking to leave SpamTitan expeditiously here. We've narrowed our focus down to Proofpoint and Avanan. I am looking for some guidance about which way you went and why. People's rationale may help me out a lot. Here's my DD so far on these two: Proofpoint Pros: Cheaper MX based so mail is screened prior to arriving Proofpoint Cons: Less AI type things Not sure what else Avanan Pros: API based so the MX records remain in tact Some cooler features Phishing training so it would make IronScales potentially redundant Very fast deployment People say it's AWESOME based on reddit Avanan Cons: More expensive It seems like users may get email notifications about junk/malicious stuff and then it is clawed back/out? Checkpoint owns it .. maybe not a con? Please clue me on on what I may be missing too here! submitted by /u/dbh2 [link] [comments] - reddit | 3h ago link | |
| GILD US | What the Options Market Tells Us About Gilead Sciences Deep-pocketed investors have adopted a bullish approach towards Gilead Sciences (NASDAQ: GILD ), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in GILD usually suggests something big is about to happen. We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Gilead Sciences. This level of activity is out of the ordinary. The general mood among these heavyweight investors is divided, with 50% leaning bullish and 50% bearish. Among these notable options, 3 are puts, totaling $93,168, and 5 are calls, amounting to $211,849. Expected Price Movements Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $65.0 to $75.0 for Gilead Sciences over - benzinga | 3h ago link | |
| CMTL US | Comtech Telecommunications (CMTL) Tanks After Revealing Liquidity Concerns, Firing CEO For Cause, Reporting Disastrous Q2 2024 Results Hagens Berman CMTL Investors with Substantial Losses Encouraged to Contact Hagens Berman, National Trial Attorneys CMTL Investors with Substantial Losses Encouraged to Contact Hagens Berman, National Trial Attorneys - globenewswire | 3h ago link | |
| SONG LSE | Hipgnosis agrees $1.4bn sale to Concord Chorus Struggling music rights business strikes deal with US rival - ft | 3h ago link | |
| TSLA US | Stocks Edge Higher As Earnings Provide Support, Tesla Sinks To 15-Month Lows, Bitcoin Rebounds: What's Driving Markets Thursday? Stocks surged higher on Thursday, with the S&P 500 index aiming to snap a four-day losing streak as investors assess the latest wave of corporate earnings. During midday trading in New York, all major indices were in the green. Notably, small caps, as tracked by the iShares Russell 2000 ETF (NYSE: IWM ), outperformed, posting a 1% increase. Industry-wise, airline stocks continued their upward momentum, with the U.S. Global Jets ETF (NYSE: JETS ) climbing 2.7%, building on Wednesday’s 3.9% surge. Tesla Inc. (NASDAQ: TSLA ) had another lackluster session, declining over 3% and on track for its lowest close since January 2023. This decline followed Deutsche Bank’s downgrade of the EV-maker from Buy to Hold, citing concerns over the strategic pivot to autonomous vehicles. On the data front, the Philadelphia Fed Manufacturing Index posted ... Full story available on Benzinga.com - benzinga | 3h ago link | |
| TSLA US | Tesla shares fall 3% as Deutsche Bank flags risks from focus on Robotaxi The company shares fell to their lowest in more than a year on Thursday. Its market capitalization is set to fall by more than $17 billion to about $478 billion, if losses hold. Still the company remains the most valuable automaker in the world. - economictimes indiatimes | 3h ago link | |
| FVRR US | Demystifying Fiverr Intl: Insights From 8 Analyst Reviews During the last three months, 8 analysts shared their evaluations of Fiverr Intl (NYSE: FVRR ), revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 1 3 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 3 0 3 0 0 3M Ago 0 1 0 0 0 Analysts have recently evaluated Fiverr Intl and provided 12-month price targets. The average target is $31.75, accompanied by a high estimate of $40.00 and a low estimate of $25.00. A 5.7% drop is evident in the current average compared to the previous average price target of $33.67. Deciphering Analyst Ratings: An In-Depth Analysis The standing of Fiverr Intl among financial experts - benzinga | 3h ago link | |
| ZG US | Zillow: Metro Boston is facing the worst inventory crunch in the US Plus, forty-nine percent of the listings sold for over the asking price in March; back in 2019, that figure was only 26%. The post Zillow: Metro Boston is facing the worst inventory crunch in the US appeared first on Boston.com . - boston | 3h ago link | |
| DOCU US | (DOCU) - Analyzing DocuSign's Short Interest DocuSign's (NYSE: DOCU ) short percent of float has risen 18.07% since its last report. The company recently reported that it has 8.38 million shares sold short , which is 4.9% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.18 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price ... Full story available on Benzinga.com - benzinga | 3h ago link | |
| COST US | Costco Gas takes Google Pay, despite it not being listed on their website At least the one I used today does. The Costco website says Costco takes Samsung/Google/Apple Pay but Costco Gas only lists Apple Pay. I had been debating getting a USBAR in the next year and the biggest negative was the thought that I was going to have to buy Costco Shop cards in order to get the 3X/4.5X points on gas. Tried GPay today at the pump today with the USB Cash+ and it worked. Perhaps this is only at select locations, but I wanted other GPay users to know it's possible. submitted by /u/bangobot46 [link] [comments] - reddit | 3h ago link | |
| ZS US | 4 Reasons Why This Zscaler Analyst Is Turning Bullish: 'Q1 Feedback Is Positive' Cybersecurity company Zscaler Inc (NASDAQ: ZS ) is considered a “ Top Pick on the Zacks Analyst Blog .” It’s also a leader in the SASE (Secure Access Service Edge) market, which is still in its 'early innings,' according to KeyBanc Capital Markets analyst Eric Heath. The Zscaler Analyst: Heath upgraded the rating for Zscaler to Overweight, while establishing a price target of $220. The Zscaler Thesis: The new price target reflects a 'modest premium' to the over 20% growth group, Heath ... Full story available on Benzinga.com - benzinga | 3h ago link | |
| BMI US | What's Going On With Badger Meter Stock Thursday? Badger Meter, Inc (NYSE: BMI ) reported fiscal first-quarter 2024 sales growth of 23% year-on-year to $196.3 million, beating the consensus of $182.3 million . EPS of $0.99 beat the consensus of $0.82 . The stock price climbed after the results. Utility water sales increased 29% year over year, reflecting continued customer adoption across its broad and expanding portfolio of smart water solutions, which encompasses its cellular ... Full story available on Benzinga.com - benzinga | 3h ago link | |
| CSX US | CSX's Guidance Remains Intact Despite Disruptions: Analysts Weigh In On Q1 Results, Outlook CSX Corp (NASDAQ: CSX ) shares have been in focus after U.S. Sen. Tommy Tubervilles latest regulatory filing . CSX also reported its first-quarter results on Wednesday, which came amid an exciting earnings season . Here are some key analyst takeaways from the release. BofA Securities On CSX Analyst Ken Hoexter maintained a Buy rating while cutting the price target from $40 to $39. CSX's first-quarter earnings declined by 2% year-year but came ahead of Street expectations, Hoexter said. 'Despite challenges from weather in January and the collapse of Baltimore’s Key Bridge, CSX reiterated its 2024 low- to mid-single digit volume and revenue growth targets, as it sees momentum across its Merchandise, Intermodal and Export Coal franchises,' the analyst added. Goldman Sachs On CSX Analyst Jordan Alliger reiterated a Buy rating and price target of $44. CSX reported operating earnings a tad ahead of expectations, with higher-than-forecast revenue produc - benzinga | 3h ago link | |
| TSLA US | Tesla's Layoffs Won't Solve Its Growing Pains The car company popularized EVs. Now, facing intense competition from China, it has to figure out what to do next. - wired | 3h ago link | |
| NFLX US | Netflix Is Enjoying An Upward Trajectory But This Chart Shows Bearish Bias Ahead Of Q1 Earnings Wall Street expects Netflix Inc (NASDAQ: NFLX ) to report $4.52 in EPS and $9.28 billion in revenues when first-quarter (Q1) earnings are released after market close . Year-to-date, the streamer’s stock is up about 27%. For the past year, it’s up 84.45%. But as Netflix heads towards reporting Q1 earnings, the technical analysis of the company’s stock points toward mixed sentiments with a slight bearish bias. See below. Netflix Stock Technical Setup Ahead Of Q1 Earnings Chart: Benzinga Pro Read: ‘Enormous 8’ Member Netflix Just Made New 52-Week High, Valuations Suggest Profit-Taking Opportunity The eight-day simple moving average (SMA) indicates bulls taking charge. Values recently crossed over the current share price. Similarly, the 20-day SMA now also lies above the share price, reinforcing positive trading sentiments. ... Full story available on Benzinga.com - benzinga | 3h ago link | |
| APLS US | Behind the Scenes of Apellis Pharmaceuticals's Latest Options Trends Whales with a lot of money to spend have taken a noticeably bearish stance on Apellis Pharmaceuticals . Looking at options history for Apellis Pharmaceuticals (NASDAQ: APLS ) we detected 13 trades. If we consider the specifics of each trade, it is accurate to state that 7% of the investors opened trades with bullish expectations and 92% with bearish. From the overall spotted trades, 2 are puts, for a total amount of $90,630 and 11, calls, for a total amount of $1,684,106. Predicted Price Range Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $40.0 to $75.0 for Apellis Pharmaceuticals over the last 3 months. Volume & Open Interest Development Looking at the volume and open interest is an insightful way to conduct due diligence on a stock. This data can help you track the liquidity and interest for Apellis Pharmaceuticals's options ... Full story available on Benzinga.com - benzinga | 3h ago link |